SII, the world's largest vaccine manufacturer, is producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor a...

The blue-chip FTSE 100 index climbed 0.5%, with healthcare stocks leading the gains, while the domestically focussed mid-cap index added 0....

In England's Tier 4, most people are advised to stay home, barred from mixing with the members of other households either indoors or out, n...

India, the world's biggest vaccine-making country, wants to start inoculating its citizens next month and is also considering emergency use...

Trials will start by the end of the year and Russia wants to jointly produce the new vaccine if it is proven to be effective, said the RDIF...

Sentiment was also bolstered by expectations that the Organization of the Petroleum Exporting Countries (OPEC), Russia and other producers,...

"This vaccine's efficacy and safety confirm that it will be highly effective against Covid-19 and will have an immediate impact on this pub...

Drugmaker AstraZeneca resumed its British clinical trials of its COVID-19 vaccine, one of the most advanced in development.

Also, Pfizer Inc rose 2.6% after the drugmaker and German biotech firm BioNTech SE proposed to expand their Phase 3 pivotal COVID-19 vaccin...

The pan-European STOXX 600 index rose 0.7% by 0711 GMT on Monday, hitting its highest level in over a week, while the German and French ind...

Data from the euro zone is expected to show service-sector growth for a second straight month.

Mark Reilly and two Chinese executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry.

In Tuesday's sessions lawmakers will also interrogate AstraZeneca's French CEO Pascal Soriot and business minister Vince Cable.

The decision to shut the R&D centre is part of an ongoing global restructuring exercise, said the company that employs over 1,200 people in...

GlaxoSmithKline is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for around $1.5 billion.

British pharma major GlaxoSmithKline Plc is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for arou...

Ranbaxy reaches an agreement with GlaxoSmithKline to settle their dispute over a US patent covering Valtrex.